Halozyme Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Halozyme Therapeutics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Halozyme Therapeutics Inc Strategy Report
- Understand Halozyme Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Halozyme Therapeutics Inc’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
15 Aug 2022 | Halozyme Therapeutics Prices Upsized Private Placement of Senior Notes Due 2028 for USD625 Million in | Debt Offering | - |
Halozyme Therapeutics Inc |
13 Apr 2022 | Halozyme Therapeutics Acquires Antares Pharma | Acquisition |
Halozyme Therapeutics Inc
|
Antares Pharma Inc
|
24 Mar 2022 | Chugai Pharma Enters into Licensing Agreement with Halozyme Therapeutics | Licensing Agreement |
Chugai Pharmaceutical Co Ltd
|
Halozyme Therapeutics Inc |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer